H2R did you buy DVAX? Their Heplisav-B vaccine got approved today.. Up over $2 AH.. Stock will be in the mid $30 next year.. EXEL, DVAX, ARTH are my biotech winners this year and of course my losers are AGEN and KERX.. I am regretting about AGEN the most.. arrrgh